Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 26, 2007

View Archived Issues

Avexa reports progress with apricitabine

NovaCal changes name to NovaBay

Plethora seeks clearance to begin phase III for PSD-502 in premature ejaculation

TorreyPines and Eisai extend Alzheimer's disease collaboration

Peregrine licensee begins phase I trial with TNT cancer agent

New phase I trial studies L-annamycin in pediatric ALL and AML

CUV-1647 significantly delays onset of erythropoietic protoporphyria pain

Development of AOD-9604 in obesity terminated following phase IIb results

Antitumor activity following GVAX immunotherapy + ipilimumab

Incyte updates pipeline advances

Phase III findings for Cimzia in rheumatoid arthritis

CureDM reports diabetes preclinical milestones

Valeant files IND for Cesamet in chemotherapy-induced neuropathic pain

Rosiglitazone linked to increased incidence of fractures in female patients

Novel synthetic diazonamide A analogue shows promise in preclinical studies

Therapeutic potential for prolactin inhibition in postpartum cardiomyopathy

(-)-Epigallocatechin-3-gallate lipophilic analogue shows antidiabetic activity in vitro and in vivo

Roche suspends recruitment in phase II CERA study

Avastin recommended for approvals in Japan, E.U.

Approvable letter for Galvus

Vyvanse approved for ADHD

Xeloda recommended for E.U. approval for advanced gastric cancer

Sebivo recommended for approval in E.U. for chronic hepatitis B

Recent patents disclose novel antiinfective agents

Novel agents for HIV infection reported in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...